---
figid: PMC5171696__HollaMCS001115_F1
figtitle: 'Anaplastic lymphoma kinase (ALK) signaling: Pathway figure that depicts
  normal activation of ALK through ligand binding'
organisms:
- NA
pmcid: PMC5171696
filename: HollaMCS001115_F1.jpg
figlink: /pmc/articles/PMC5171696/figure/HOLLAMCS001115F1/
number: F1
caption: 'Anaplastic lymphoma kinase (ALK) signaling: Pathway figure that depicts
  normal activation of ALK through ligand binding. Receptor phosphorylation stimulates
  downstream signaling through the PI3K/AKT, MAPK/ERK, and STAT3 pathways. These signaling
  cascades can contribute to increased cancer cell growth, survival, and metastasis.'
papertitle: 'ALK: a tyrosine kinase target for cancer therapy.'
reftext: Vijaykumar R. Holla, et al. Cold Spring Harb Mol Case Stud. 2017 Jan;3(1):a001115.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9572827
figid_alias: PMC5171696__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5171696__F1
ndex: 8eee8bfc-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5171696__HollaMCS001115_F1.html
  '@type': Dataset
  description: 'Anaplastic lymphoma kinase (ALK) signaling: Pathway figure that depicts
    normal activation of ALK through ligand binding. Receptor phosphorylation stimulates
    downstream signaling through the PI3K/AKT, MAPK/ERK, and STAT3 pathways. These
    signaling cascades can contribute to increased cancer cell growth, survival, and
    metastasis.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Su(var)3-9
  - mk
  - Alk
  - sl
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Stat92E
  - bsk
  - Akt
  - Raf
  - Jra
  - Dsor1
  - Mtor
  - Tor
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - AP-1gamma
  - kay
  - rl
  - PTN
  - ALK
  - PLCG1
  - PLCG2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - JUN
  - JUNB
  - JUND
  - MAP2K1
  - MAP2K2
  - MTOR
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - FOS
  - FOSB
  - MAPK3
  - MAPK1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
